ENTITY

CSL (CSL AT)

2
Analysis
Health Care • United States
CSL Limited develops, manufactures, and markets human pharmaceutical and diagnostic products derived from human plasma. The Company provides products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
•05 Jul 2024 06:00

ASX Short Interest Weekly (Jun 28th): Macquarie, Westpac, CSL, Pro Medicus, Yancoal Australia

We analyzed ASX short interest report for the past week and highlight short interest changes in Macquarie, Westpac, CSL, Pro Medicus, Yancoal...

Logo
588 Views
Share
•21 Jun 2024 11:01

ASX Short Interest Weekly (Jun 14th): BHP, Champion Iron, Woolworths

We analyzed ASX short interest report for the past week and highlight short interest changes in BHP, Champion Iron, Woolworths.

Logo
586 Views
Share
•07 Jun 2024 10:03

ASX Short Interest Weekly (May 31st): Wisetech Global, Pro Medicus, CSL, IDP Education, Boral

We analyzed ASX short interest report for the past week and highlight short interest changes in Wisetech Global, Pro Medicus, CSL, IDP Education,...

Logo
683 Views
Share
bullish•Terumo Corp
•23 May 2024 22:41

Terumo Corp (4543 JP): Q4 Result Beats Guidance; Double-Digit Profit Growth to Continue in FY25

​Terumo reported 18% revenue growth in Q4FY24, with operating profit up 45%. FY25 outlook includes revenue of ¥980B, op. profit of ¥165B, and net...

Logo
471 Views
Share
•01 Apr 2024 05:00

Australia Short Interest (Q1 2024): A Recap

Total short interest in Australia is A$34.46bn and has decreased by A$1.36bn since the start of the year. We look at the stocks with the largest...

Logo
526 Views
Share
x